Who owns CRISPR-Cas9 in Europe?

Nature Biotechnology

Volumn 32, Issue 12, 2014, Pages 1194-1196

  Kupecz, András ^a  

^a Kupecz Intellectual Property   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 9; POLYNUCLEOTIDE;

ARTICLE; CRISPR CAS SYSTEM; EUKARYOTIC CELL; EUROPE; GENOME; NONHUMAN; NUCLEOTIDE SEQUENCE; PATENT; PRIORITY JOURNAL; UNITED STATES; HUMAN; HUMAN GENOME;

CRISPR-CAS SYSTEMS; EUROPE; GENOME, HUMAN; HUMANS; INTELLECTUAL PROPERTY; PATENTS AS TOPIC; UNITED STATES;

EID: 84924333079     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.3086     Document Type: Article

References (8)

1. Hsu, P.D. et al. Cell 157, 1262-1278 (2014).
2. Sheridan, C. Nat. Biotechnol. 32, 599-601 (2014).
3. Zhang, F. CRISPR-Cas systems and methods for altering expression of gene products. US patent 8697359 (2014).
4. Zhang, F. CRISPR-Cas systems and methods for altering expression of gene products. EP2764103 (2014).
5. Article 54(3) European Patent Convention.
6. https://register.epo.org/application?number=EP13824232&lng=en&tab=doclist
7. Letter of the applicant (the Broad Institute and MIT) dated 2 October, 2014. https://register.epo.org/application?number=EP13824232&lng=en&tab=doclist
8. Jinek, M. et al. Science 337, 816-821 (2012).